Clinical Trial Update: Treating Nicotine Dependence in Schizophrenic Individuals: Effectiveness of Bupropion - 1 [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the effectiveness of bupropion for nicotine dependence in individuals with schizophrenia and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia
• Tobacco Use Disorder

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Cessation, Tobacco Use Disorder | Phase 2 | Status: COMPLETED